June 25, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Healthcare & Insurance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Intiva BioPharma Inc. |
Registration Statement on Form S-1 | |
File No. 333-225477 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 PM (Eastern time) on Wednesday, June 27, 2018, or as soon thereafter as is practicable.
Very truly yours, | ||
INTIVA BIOPHARMA INC. | ||
By: | /s/ Alain Bankier | |
Alain Bankier | ||
Chief Executive Officer |